LY3090106

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

HealthySjögren's Syndrome

Phase 1

A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)

CompletedNCT02614716

Eli Lilly and CompanySjögren's Syndrome

Start: 2015-12-10End: 2018-09-05Updated: 2018-12-11

A Study of LY3090106 in Japanese and Caucasian Healthy Participants

CompletedNCT03736772

Eli Lilly and CompanyHealthy

Start: 2018-11-19End: 2019-03-13Updated: 2019-05-03